SORENSEN MEL (President and CEO) reported 1 transaction at GALERA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/5/2026ACC: 0001193125-26-335499
DirectorOfficer· President and CEO
Since Nov 2019
-30.98K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
30.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−975.00
Price / share
—
Trade value
—
% of position
New position
8/3/2026
975.00→0.00
Total
Net shares
−975.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | D · Disposition | −975.00 | — | — | New position | 975.00 | 0.00 |
| Total | −975.00 | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
4.4
Held after
0.00
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30K shares | 8/3/2026 | D · Disposition | −30K | 4.4 | — | 0.00 |